CI_with has_DoseForm has_Ingredient has_MoA has_PE may_prevent may_treat drug associated with AE Coronary Artery Disease [Disease/Finding] Drug Hypersensitivity [Disease/Finding] Gallbladder Diseases [Disease/Finding] Hypercholesterolemia [Disease/Finding] Hyperlipoproteinemias [Disease/Finding] Liver Cirrhosis, Biliary [Disease/Finding] Hypertriglyceridemia [Disease/Finding] Liver Failure [Disease/Finding] Kidney Failure [Disease/Finding] Fenofibrate [Chemical/Ingredient] Decreased Lipolysis [PE] Unknown Cellular or Molecular Interaction [MoA] [CV350] ANTILIPEMIC AGENTS Oral Tablet [Dose Form] FENOFIBRATE FENOFIBRATE 40MG TAB [VA Product] 4027543 Fenofibrate 40 MG Oral Tablet FENOFIBRATE TAB 非诺贝特分散片 C50.68.19636 40 C1967443 MG N0000177375 非诺贝特片 <VANDF_Record>50.68^19636^Active/Master</VANDF_Record><VA_File>50.68</VA_File><VA_IEN>19636</VA_IEN><VA_Status>Active/Master</VA_Status> <Product_Component>FENOFIBRATE</Product_Component><Strength>40</Strength><Unit>MG</Unit><VA.IEN>3766</VA.IEN> 0 FENOFIBRATE 40MG TAB 非诺贝特咀嚼片 FENOFIBRATE 40MG TAB 749804 VA Product fatigue AE abdominal discomfort AE rash AE headache AE vertigo AE myopathy AE constipation AE myositis AE diarrhea AE erectile dysfunction AE rhabdomyolysis AE transaminase level increased AE increased biliary calculus AE change of hematology AE loss of libido AE insomnia AE mild change of hematology AE moderate change of hematology AE increased tendency of biliary calculus AE FENOFIBRATE 40MG TAB [VA Product] <VANDF_Record>50.68^19636^Active/Master</VANDF_Record><VA_File>50.68</VA_File><VA_IEN>19636</VA_IEN><VA_Status>Active/Master</VA_Status> N0000177375 <Product_Component>FENOFIBRATE</Product_Component><Strength>40</Strength><Unit>MG</Unit><VA.IEN>3766</VA.IEN> 0 4027543 Fenofibrate 40 MG Oral Tablet 非诺贝特片 FENOFIBRATE 40MG TAB 非诺贝特咀嚼片 FENOFIBRATE TAB FENOFIBRATE 40MG TAB 非诺贝特分散片 40 C50.68.19636 VA Product 749804 C1967443 MG